These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4318491)

  • 21. [Biological factors influencing response to diuretics in patients with cirrhosis and ascites].
    Lenaerts A; Codden T; Henry JP; Van Cauter J; Meunier JC; Ligny G
    Gastroenterol Clin Biol; 2001 Mar; 25(3):268-72. PubMed ID: 11395674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of the renin-angiotensin-aldosterone system in ascitic hepatic cirrhosis. Effects of inhibition of angiotensin I converting enzyme].
    Santucci A; Aguglia F; De Mattia G; Cammarella I; Trinchieri F; Giordano M; Gnecchi M; Ficara C
    Clin Ter; 1983 Jul; 106(2):121-4. PubMed ID: 6313280
    [No Abstract]   [Full Text] [Related]  

  • 23. [Transient anuria in decompensated liver cirrhosis during angiotensin (Hypertensin) infusion].
    Radó J; Borbély L; Kalcseva S; Takó J; Szende L
    Orv Hetil; 1969 Feb; 110(8):407-10. PubMed ID: 4305316
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathogenesis and therapy of ascites in hepatic cirrhosis].
    Persico L
    Policlinico Prat; 1971 Feb; 78(3):100-9. PubMed ID: 5572866
    [No Abstract]   [Full Text] [Related]  

  • 25. Angiotensin II and renal excretion of sodium and potassium in unanaesthetized dogs.
    Børresen HC; Rørvik S; Guldvog I; Aakvaag A
    Scand J Clin Lab Invest; 1982 Feb; 42(1):87-92. PubMed ID: 7134792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of single oral low-dose losartan on posture-related sodium handling in post-TIPS ascites-free cirrhosis.
    Therapondos G; Hol L; Benjaminov F; Wong F
    Hepatology; 2006 Sep; 44(3):640-9. PubMed ID: 16941706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience in the treatment of water-salt retentions in cirrhosis by the antialdosterone 11614 R.P].
    Boivin P; Fauvert R
    Rev Int Hepatol; 1969; 19(4):241-51. PubMed ID: 5404532
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of angiotensin on cirrhotics].
    Galea G; Varlas A; Bucur G
    Med Interna (Bucur); 1972 May; 24(5):515-9. PubMed ID: 4340437
    [No Abstract]   [Full Text] [Related]  

  • 29. Renal failure in advanced liver disease.
    Baldus WP
    Prog Liver Dis; 1972; 4():251-67. PubMed ID: 4347066
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.
    Bosch J; Arroyo V; Betriu A; Mas A; Carrilho F; Rivera F; Navarro-Lopez F; Rodes J
    Gastroenterology; 1980 Jan; 78(1):92-9. PubMed ID: 7350041
    [No Abstract]   [Full Text] [Related]  

  • 32. [The renin-angiotensin-aldosterone system in liver cirrhosis].
    Chmielewska J
    Przegl Lek; 1983; 40(8):619-22. PubMed ID: 6364257
    [No Abstract]   [Full Text] [Related]  

  • 33. [The pathogenesis of ascites and of edema in hepatic cirrhosis].
    Perosa L
    Recenti Prog Med; 1966 Jan; 40(1):21-42. PubMed ID: 5325503
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of aldosterone in edema formation.
    Wolff HP; Blaise BH; Düsterdieck G; Jahnecke J; Kobayashi T; Krück F; Lommer D; Schieffer H
    Ann N Y Acad Sci; 1966 Nov; 139(2):285-94. PubMed ID: 4291331
    [No Abstract]   [Full Text] [Related]  

  • 35. [The Renin-Angiotensin-Aldosterone system in kidney diseases].
    Distler A
    Z Allgemeinmed; 1974 Apr; 50(12):576-9. PubMed ID: 4365857
    [No Abstract]   [Full Text] [Related]  

  • 36. Renin-angiotensin-aldosterone in cirrhotic ascites.
    Martin A; Sturniolo GC; Naccarato R
    Gastroenterology; 1980 May; 78(5 Pt 1):1122-3. PubMed ID: 6991356
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fluid retention in cirrhosis].
    Henriksen JH
    Ugeskr Laeger; 1995 Nov; 157(48):6733-4. PubMed ID: 8540141
    [No Abstract]   [Full Text] [Related]  

  • 38. [Considerations on the treatment of edemato-ascitic syndromes of hepatic origin. Apropos of the utilization of an antialdosterone].
    Levrat R; Savoye B; Imbert D
    J Med Lyon; 1968 Dec; 49(154):1887-99. PubMed ID: 5712102
    [No Abstract]   [Full Text] [Related]  

  • 39. Aldosterone, angiotensin II, and renal salt sparing.
    Borresen HC
    Scand J Clin Lab Invest; 1982 Feb; 42(1):93-6. PubMed ID: 7134794
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of furosemide on liver cirrhosis patients with ascites].
    De Los Reyes MP; Bardi A; Carrillo E; Generini G
    Rev Med Chil; 1966 Mar; 94(3):149-54. PubMed ID: 5986934
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.